Related Experiment Videos

Radionuclide measurement of left ventricular ejection fraction in infants and children

British Heart Journal
|March 1, 1984
PubMed

Insights

Equilibrium gated radionuclide angiography is a reliable method for assessing left ventricular function in pediatric congenital heart disease patients. This technique shows good correlation with cineangiography, even in infants.

Area of Science:

  • Pediatric Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Congenital heart disease (CHD) significantly impacts cardiac function in infants and children.
  • Accurate measurement of left ventricular ejection fraction (LVEF) is crucial for managing pediatric CHD.
  • Non-invasive imaging techniques are preferred for pediatric cardiac assessment.

Purpose of the Study:

  • To evaluate the accuracy of equilibrium gated radionuclide angiography (EGRNA) in measuring LVEF in pediatric patients with CHD.
  • To compare EGRNA measurements with biplane left ventricular cineangiography (LVCA).
  • To assess the reliability of EGRNA across different age groups and shunt types in pediatric CHD.

Main Methods:

  • Sixty infants and children with CHD underwent LVEF measurement using both EGRNA and biplane LVCA.
  • Patients' median age was 2.25 years, with 17 under 1 year old.
  • Subgroup analysis included age (<1 year) and shunt type (left-to-right, right-to-left).

Main Results:

  • A good correlation coefficient was observed between EGRNA and LVCA for LVEF measurements.
  • The correlation remained strong in younger children (<1 year) and those with large left-to-right shunts.
  • A weaker correlation was noted in infants with right-to-left shunts.

Conclusions:

  • Equilibrium gated radionuclide angiography is a valid and clinically useful tool for assessing left ventricular function in pediatric patients with congenital heart disease.
  • EGRNA provides reliable LVEF data, particularly in younger children and those with left-to-right shunts.
  • Further investigation may be warranted for EGRNA's utility in infants with right-to-left shunts.

Related Concept Videos